RIFM’s Api Honored with Toxicology Award

Anne Marie Api, Ph.D., vice president, human health science at RIFM, will receive the Philippe Shubik Distinguished Scientist Award from The Toxicology Forum.


The global award, given annually, honors an individual who has had a long and productive career in the field of toxicology and has made significant and noteworthy contributions to the field. Conditions of the award include all aspects of traditional and regulatory toxicology and the support and mentoring of other toxicologists. The Philippe Shubik Distinguished Scientist Award is presented at the winter meeting of The Toxicology Forum. Dr. Api will deliver a lecture following the award presentation.


Api joined RIFM in 1984 and directs the extensive human health science program—dermatotoxicology, repeated dose toxicity, reproduction, human exposure, respiratory, computational toxicology and safety assessments. She was a co-founder of the RIFM Database, a lead author of the Quantitative Risk Assessment (QRA) for Fragrance Ingredients that guides the fragrance industry global standards, and contributed her expertise to its successor the QRA2, which incorporates the Creme RIFM Aggregate Exposure Model. Dr. Api was the project leader for the Aggregate Exposure Model designed by Creme Global. The model provides the crucial real-life, aggregated fragrance material exposure data for the QRA2 and the RIFM Safety Assessments. She was one of the scientists who led RIFM into its non-animal approach in the early 2000s and she continues to drive RIFM in expanding its use of alternative methods and models. Dr. Api is a co-designer of the ground-breaking EDEN project that quantifies the true prevalence of contact allergy in the general population.


More info: www.rifm.org